Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies

Conjugation Tech Could Improve Gene Delivery

 
• By Andrew McConaghie

The company aims to overcome drawbacks of existing gene therapy platforms, starting in ocular and CNS diseases.

Eye test in France
Rare genetic eye diseases have been among the first targets for pioneering gene therapies. • Source: Alamy

More from Business

More from Scrip